Publications authored by the geneXplain team

Kisakol, B., Matveeva, A., Salvucci, M., Kel, A., McDonough, E., Ginty, F., Longley, D. B., & Prehn, J. H. M. (2024). Identification of unique rectal cancer-specific subtypes. British journal of cancer, 130(11), 1809–1818. Link

Kolpakov, F., Akberdin, I., Kiselev, I., Kolmykov, S., Kondrakhin, Y., Kulyashov, M., Kutumova, E., Pintus, S., Ryabova, A., Sharipov, R., Yevshin, I., Zhatchenko, S., & Kel, A. (2022). BioUML-towards a universal research platform. Nucleic Acids Res. 50(W1),W124–31. Link

Orekhov A.N., Sukhorukov V.N., Nikiforov N.G., Kubekina M.V., Sobenin I.A., Foxx K.K., Pintus S., Stegmaier P., Stelmashenko D., Kel A., Poznyak A.V., Wu W.K., Kasianov A.S., Makeev V.Y., Manabe I., Oishi Y. (2020) Signaling Pathways Potentially Responsible for Foam Cell Formation: Cholesterol Accumulation or Inflammatory Response-What is First? Int J Mol Sci. 21(8),2716. Link

Kel A., Boyarskikh U., Stegmaier P., Leskov L.S., Sokolov A.V., Yevshin I., Mandrik N., Stelmashenko D., Koschmann J., Kel-Margoulis O., Krull M., Martínez-Cardús A., Moran S., Esteller M., Kolpakov F., Filipenko M., Wingender E. (2019) Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer. BMC Bioinformatics. 20(Suppl 4),119. Link

Boyarskikh, U., Pintus, S., Mandrik, N., Stelmashenko, D., Kiselev, I., Evshin, I., Sharipov, R., Stegmaier, P., Kolpakov, F., Filipenko, M., Kel, A. (2018) Computational master-regulator search reveals mTOR and PI3K pathways responsible for low sensitivity of NCI-H292 and A427 lung cancer cell lines to cytotoxic action of p53 activator Nutlin-3. BMC Med. Genomics 11(Suppl 1), 12. Link

Kel, A.E., Stegmaier, P., Valeev, T., Koschmann, J., Poroikov, V., Kel-Margoulis, O.V. and Wingender, E. (2016) Multi-omics “upstream analysis” of regulatory genomic regions helps identifying targets against methotrexate resistance of colon cancer. EuPA Open Proteomics 13, 1-13. Link